Adagene Inc. (ADAG)

NASDAQ: ADAG · USD

$2.35

+0.06 (+2.6%)· Recorded snapshot

Market cap	157.8M
Revenue (ttm)	9.3M
Net income (ttm)	-20.5M
EPS (ttm)	-$0.39
Shares out	67.1M
Volume	107,351.354
Beta	0.66

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.3M
Net income (ttm): -20.5M
EPS (ttm): -$0.39
Market cap: 157.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-28.5

P25 -113.8P50 -46.5P75 -0.9

ROIC-17.8

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All ADAG indicators

Market & fundamental data

Available fields

202

Groups with data

Currency

USD

Showing 202 of 202 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001818838
Company name	Adagene Inc.
Country	China
Country code	US
CUSIP number	005329107
Earnings date	2026-08-12
Earnings time	bmo
Employees	128
Employees change	-10
Employees growth	-7.25%
Enterprise value	$36M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2011
Industry	Biotechnology
IPO date	2021-02-09
Is primary listing	Yes
Is SPAC	No
ISIN number	US0053291078
Last 10-K release date	2026-04-01
Last earnings date	2026-08-12
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$157.8M
Market cap category	Micro-Cap
Next earnings date	2027-03-31
Options	No
Price	$2.35
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	ADAG
Website	https://www.adagene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-16.8%
EV/Sales	3.87x
FCF / EV yield	-53.99%
FCF yield	-12.31%
P/B ratio	1.76x
P/S ratio	16.98x
Price / tangible book value	1.76x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-240.42%
EBITDA margin	-236.28%
Gross margin	100%
Operating margin	-240.42%
Pretax margin	-224.71%
Profit margin	-220.77%
Profit per employee	$-160,242
Revenue per employee	$72,584
ROA	-13.95%
ROA (5Y)	-22.54%
ROCE	-20.83%
ROE	-28.5%
ROE (5Y)	-49.41%
ROIC	-17.8%
SBC / revenue	41.36%
Tax / revenue	-3.94%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	8,902.38%
Gross profit growth 3Y	-25.72%
Gross profit growth 5Y	39.63%
Net income growth years	1
Revenue growth	8,902.38%
Revenue growth (QoQ)	-78.88%
Revenue growth 3Y	-25.72%
Revenue growth 5Y	39.63%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-170,783
Depreciation and amortization	$384,223
EBIT	$-22.3M
EBITDA	$-22M
EPS	$-0.39
FCF per share	$-0.29
Financing cash flow	$83.9M
Free cash flow	$-19.4M
Free cash flow minus SBC	$-23.3M
Gross profit	$9.3M
Income taxes	$-366,334
Investing cash flow	$733,401
Net borrowing	$-1.2M
Net cash flow	$65.1M
Net income	$-20.5M
Operating cash flow minus SBC	$-23.1M
Operating income	$-22.3M
Revenue	$9.3M
Stock-based compensation	$3.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.08
Book value per share	$1.33
Debt / equity	0.06
Interest coverage	-78.36
Long-term assets	$1.2M
Long-term liabilities	$1.2M
Net cash (debt)	$121.8M
Net cash / market cap	77.2%
Net cash growth	62.68%
Net debt / equity	-1.15
Piotroski F-Score	3
Property, plant and equipment	$1.1M
Shareholders' equity	$106M
Tangible book value	$89.5M
Tangible book value per share	$1.33
Total assets	$133.6M
Total cash	$127.9M
Total debt	$6.1M
Total liabilities	$27.6M
WACC	7.7%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.09
Current assets	$132.4M
Current liabilities	$26.4M
Current ratio	5.02
Net working capital	$-17M
Quick ratio	4.86
Working capital	$106M
Working capital turnover	0.11

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-11.73%
Dividend yield	0%
Shareholder yield	-11.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$3.52
1D price change	2.62%
1M price change	-17.54%
1M total return	-17.54%
1W price change	-8.91%
1W total return	-8.91%
1Y price change	32.02%
1Y return CAGR	32.05%
1Y total return	32.02%
20-day SMA	$2.50
200-day SMA	$3.43
3M price change	-37.33%
3M total return	-37.33%
3Y price change	73.82%
3Y return CAGR	20.24%
3Y total return	73.84%
50-day SMA	$2.99
50-day SMA vs 200-day SMA	50under200
52-week high	$4.85
52-week high date	2026-07-01
52-week low	$1.30
52-week low date	2025-11-07
5Y price change	-79.57%
5Y return CAGR	-27.21%
5Y total return	-79.57%
6M price change	-38.48%
6M total return	-38.48%
After-hours change	-0.43%
After-hours close	$2.35
After-hours price	$2.34
All-time high	$31.83
All-time high date	2021-02-11
All-time low	$0.90
All-time low date	2022-10-25
Average true range (ATR)	$0.26
Average volume	315.3K
Beta (1Y)	0.65
Beta (2Y)	0.31
Beta (5Y)	0.66
Change from 52-week high	-51.55%
Change from 52-week low	80.77%
Change from all-time high	-92.62%
Change from all-time low	161.11%
Change from open	4.44%
Day's gap	-1.75%
Dollar volume	$252,276
High price	$2.54
Low price	$2.25
Monthly RSI	42.5
Open price	$2.25
Position in 52-week range	35.09%
Previous close	$2.29
Price vs 150-day SMA	-33.3%
Price vs 20-day SMA	-5.85%
Price vs 200-day SMA	-31.45%
Price vs 50-day SMA	-21.3%
Relative volume	0.34
Return from IPO open	-88.48%
Return from IPO price	-87.63%
RSI	40.16
Sharpe ratio	0.71
Sharpe ratio (3Y)	0.62
Sharpe ratio (5Y)	0.03
Sortino ratio	1.23
Sortino ratio (3Y)	1.04
Sortino ratio (5Y)	0.12
Volume	107.4K
Weekly RSI	39.84
YTD price change	24.34%
YTD total return	24.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44.8M
Float percentage	66.76%
Shares change (QoQ)	19.71%
Shares change (YoY)	11.73%
Shares held by insiders	10.11%
Shares held by institutions	43.21%
Shares outstanding	67.1M
Short % of shares	3.7%
Short ratio	5.5 days

Deeper analysis on ADAG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ADAG report

Is a complete ADAG research report available?

No complete published report is available for Adagene Inc. (ADAG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Adagene Inc. (ADAG)

Price

Financial snapshot

Fair-value bridge

Latest news · ADAG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ADAG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ADAG

Frequently asked questions